Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Corrigendum: Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A.

Nat Immunol. 2016 Sep 20;17(10):1235. doi: 10.1038/ni1016-1235a. No abstract available.

PMID:
27648550
2.

EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.

Ma J, Nie K, Redmond D, Liu Y, Elemento O, Knowles DM, Tam W.

Leukemia. 2016 Mar;30(3):594-604. doi: 10.1038/leu.2015.285. Epub 2015 Nov 4.

3.

Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications.

Boiocchi L, Gianelli U, Iurlo A, Fend F, Bonzheim I, Cattaneo D, Knowles DM, Orazi A.

Mod Pathol. 2015 Nov;28(11):1448-57. doi: 10.1038/modpathol.2015.100. Epub 2015 Sep 4.

4.

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.

Al-Kawaaz M, Mathew S, Liu Y, Gomez ML, Chaviano F, Knowles DM, Orazi A, Tam W.

Am J Clin Pathol. 2015 Feb;143(2):288-99. doi: 10.1309/AJCPUIDW2CPTA1JA.

PMID:
25596256
5.

Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.

Zhang T, Ma J, Nie K, Yan J, Liu Y, Bacchi CE, Queiroga EM, Gualco G, Sample JT, Orazi A, Knowles DM, Tam W.

Blood Cancer J. 2014 Nov 7;4:e261. doi: 10.1038/bcj.2014.75.

6.

Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma.

Yan J, Nie K, Mathew S, Tam Y, Cheng S, Knowles DM, Orazi A, Tam W.

Blood Cancer J. 2014 May 30;4:e215. doi: 10.1038/bcj.2014.36. No abstract available.

7.

Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage.

Boiocchi L, Mathew S, Gianelli U, Iurlo A, Radice T, Barouk-Fox S, Knowles DM, Orazi A.

Mod Pathol. 2013 Dec;26(12):1577-85. doi: 10.1038/modpathol.2013.109. Epub 2013 Jun 21.

8.

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.

Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, Fend F, Orazi A.

Mod Pathol. 2013 Feb;26(2):204-12. doi: 10.1038/modpathol.2012.165. Epub 2012 Sep 28.

9.

Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).

Geyer JT, Verma S, Mathew S, Wang YL, Racchumi J, Espinal-Witter R, Subramaniyam S, Knowles DM, Orazi A.

Hum Pathol. 2013 Mar;44(3):346-56. doi: 10.1016/j.humpath.2012.05.022. Epub 2012 Sep 17.

PMID:
22995330
10.

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A.

J Immunol. 2012 Jun 15;188(12):6071-83. doi: 10.4049/jimmunol.1102066. Epub 2012 May 16.

11.

Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.

Boiocchi L, Witter RE, He B, Subramaniyam S, Mathew S, Nie K, Cerutti A, Coleman M, Knowles DM, Orazi A, Tam W.

Am J Clin Pathol. 2012 Apr;137(4):647-59. doi: 10.1309/AJCPHXO5UGW2OELA.

PMID:
22431543
12.

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.

Prakash S, Hoffman R, Barouk S, Wang YL, Knowles DM, Orazi A.

Mod Pathol. 2012 Jun;25(6):815-27. doi: 10.1038/modpathol.2012.33. Epub 2012 Mar 2.

13.

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.

Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, de Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A.

Nat Immunol. 2011 Dec 25;13(2):170-80. doi: 10.1038/ni.2194. Erratum in: Nat Immunol. 2014 Feb;15(2):205.

14.

Differences in breast tissue oxygenation following radiotherapy.

Dornfeld K, Gessert CE, Renier CM, McNaney DD, Urias RE, Knowles DM, Beauduy JL, Widell SL, McDonald BL.

Radiother Oncol. 2011 Aug;100(2):289-92. doi: 10.1016/j.radonc.2011.02.004. Epub 2011 Feb 26.

PMID:
21356563
15.

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma.

Chiu A, Czader M, Cheng L, Hasserjian RP, Wang M, Bhagavathi S, Hyjek EM, Al-Ahmadie H, Knowles DM, Orazi A.

Mod Pathol. 2011 Jan;24(1):108-16. doi: 10.1038/modpathol.2010.168. Epub 2010 Sep 17.

16.

Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.

Nie K, Zhang T, Allawi H, Gomez M, Liu Y, Chadburn A, Wang YL, Knowles DM, Tam W.

Am J Pathol. 2010 Sep;177(3):1470-9. doi: 10.2353/ajpath.2010.091291. Epub 2010 Jul 22.

17.

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.

Chen YT, Chadburn A, Lee P, Hsu M, Ritter E, Chiu A, Gnjatic S, Pfreundschuh M, Knowles DM, Old LJ.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3093-8. doi: 10.1073/pnas.0915050107. Epub 2010 Jan 26.

18.

Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.

Song Z, Lu P, Furman RR, Leonard JP, Martin P, Tyrell L, Lee FY, Knowles DM, Coleman M, Wang YL.

Clin Cancer Res. 2010 Jan 15;16(2):587-99. doi: 10.1158/1078-0432.CCR-09-1519. Epub 2010 Jan 12.

19.

Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.

Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR, Knowles DM, Orazi A, Tam W.

Am J Clin Pathol. 2009 Dec;132(6):928-39. doi: 10.1309/AJCPWQ0I0DGXBMHO.

PMID:
19926586
20.

HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Xu W, Santini PA, Sullivan JS, He B, Shan M, Ball SC, Dyer WB, Ketas TJ, Chadburn A, Cohen-Gould L, Knowles DM, Chiu A, Sanders RW, Chen K, Cerutti A.

Nat Immunol. 2009 Sep;10(9):1008-17. doi: 10.1038/ni.1753. Epub 2009 Aug 2.

21.

Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.

Chiu A, Frizzera G, Mathew S, Hyjek EM, Chadburn A, Tam W, Knowles DM, Orazi A.

Mod Pathol. 2009 Nov;22(11):1507-17. doi: 10.1038/modpathol.2009.106. Epub 2009 Jul 24.

22.

The stromal composition of mast cell aggregates in systemic mastocytosis.

Chiu A, Nanaji NM, Czader M, Gheorghe G, Knowles DM, Chadburn A, Orazi A.

Mod Pathol. 2009 Jul;22(7):857-65. doi: 10.1038/modpathol.2009.53. Epub 2009 Apr 24.

23.

Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.

Di Bartolo DL, Hyjek E, Keller S, Guasparri I, Deng H, Sun R, Chadburn A, Knowles DM, Cesarman E.

J Virol. 2009 May;83(9):4308-15. doi: 10.1128/JVI.02196-08. Epub 2009 Feb 18.

24.

Outcome of deferred initial therapy in mantle-cell lymphoma.

Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, Elstrom R, Niesvizky R, Ely S, Diliberto M, Melnick A, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP.

J Clin Oncol. 2009 Mar 10;27(8):1209-13. doi: 10.1200/JCO.2008.19.6121. Epub 2009 Feb 2.

PMID:
19188674
25.

Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.

Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E.

Am J Clin Pathol. 2008 Dec;130(6):957-62. doi: 10.1309/AJCP12HIRWSRQLAN.

26.

Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM.

Histopathology. 2008 Nov;53(5):513-24. doi: 10.1111/j.1365-2559.2008.03144.x.

PMID:
18983461
27.

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

Yang C, Lu P, Lee FY, Chadburn A, Barrientos JC, Leonard JP, Ye F, Zhang D, Knowles DM, Wang YL.

Leukemia. 2008 Sep;22(9):1755-66. doi: 10.1038/leu.2008.163. Epub 2008 Jul 3.

PMID:
18596745
28.

MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.

Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W.

Am J Pathol. 2008 Jul;173(1):242-52. doi: 10.2353/ajpath.2008.080009.

29.

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.

Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, Fusco E, Glynn P, Elstrom R, Niesvizky R, Feldman EJ, Shore TB, Schuster MW, Ely S, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP.

Ann Oncol. 2008 Jul;19(7):1327-30. doi: 10.1093/annonc/mdn045. Epub 2008 Mar 17.

PMID:
18349031
30.

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.

Wang YL, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, Coleman M.

Acta Haematol. 2007;118(4):209-14. Epub 2007 Nov 21.

PMID:
18032883
31.

Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.

He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, Knowles DM, Rescigno M, Cerutti A.

Immunity. 2007 Jun;26(6):812-26.

32.

Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.

Xu W, He B, Chiu A, Chadburn A, Shan M, Buldys M, Ding A, Knowles DM, Santini PA, Cerutti A.

Nat Immunol. 2007 Mar;8(3):294-303. Epub 2007 Jan 28.

PMID:
17259987
33.

Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas.

Tam W, Gomez MF, Chadburn A, Knowles DM, Houldsworth J.

Genes Chromosomes Cancer. 2007 Apr;46(4):416-8. No abstract available.

PMID:
17205536
34.

Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.

Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A.

Hum Pathol. 2007 Feb;38(2):308-14. Epub 2006 Nov 13.

PMID:
17097130
35.
36.

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.

Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A.

Blood. 2007 Jan 15;109(2):729-39. Epub 2006 Sep 7.

37.
38.

HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.

He B, Qiao X, Klasse PJ, Chiu A, Chadburn A, Knowles DM, Moore JP, Cerutti A.

J Immunol. 2006 Apr 1;176(7):3931-41.

39.

Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A.

Nat Immunol. 2006 Mar;7(3):302-10. Epub 2006 Jan 22. Erratum in: Nat Immunol. 2016 Sep 20;17(10):1235.

PMID:
16429138
40.

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM.

Blood. 2006 May 15;107(10):4090-100. Epub 2006 Jan 19.

PMID:
16424392
41.

Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.

Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, Knowles DM, Lane J, Chen-Kiang S.

Cancer Res. 2005 Dec 15;65(24):11345-53.

42.

Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association.

Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM.

J Virol. 2005 Jan;79(2):1244-51.

43.

KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma.

Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM.

Am J Surg Pathol. 2004 Nov;28(11):1401-16.

PMID:
15489644
44.

Immunophenotypic and genotypic characterization of progression in follicular lymphomas.

Natkunam Y, Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM, Warnke R.

Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):97-104.

PMID:
15354733
45.

Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.

He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A.

J Immunol. 2004 Mar 1;172(5):3268-79. Erratum in: J Immunol. 2004 Apr 15;172(8):following 5127.

46.

Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma.

Knowles DM.

Hematol Oncol Clin North Am. 2003 Jun;17(3):785-820. Review.

PMID:
12852656
47.

Alterations of mRNA splicing in primary effusion lymphomas.

Li Z, Pan L, Cesarman E, Knowles DM.

Leuk Lymphoma. 2003 May;44(5):833-40.

PMID:
12802923
48.

Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.

Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM.

Am J Surg Pathol. 2003 Mar;27(3):293-302.

PMID:
12604885
49.

DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization.

Chiu A, Pan L, Li Z, Ely S, Chadburn A, Knowles DM.

Am J Pathol. 2002 Oct;161(4):1349-55.

50.

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Müller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM.

Histopathology. 2002 Jul;41(1):1-29.

PMID:
12121233

Supplemental Content

Loading ...
Support Center